Fresenius Kabi Acquires Ivenix
March 31, 2022
Ivenix, Inc. has entered into a definitive agreement to be acquired by Fresenius Kabi for an upfront payment of $240 million plus additional milestone payments. The deal brings Ivenix's next-generation infusion pump technology and software together with Fresenius Kabi's IV fluids and infusion therapy portfolio to create a comprehensive infusion offering and accelerate U.S. commercial expansion.
- Buyers
- Fresenius Kabi
- Targets
- Ivenix, Inc.
- Industry
- Medical Devices
- Location
- Massachusetts, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Nautic Partners Completes Growth Investment in KabaFusion
February 2, 2026
Healthcare Services
Nautic Partners has completed a growth investment in KabaFusion, a national provider of home and alternative-site infusion services. KabaFusion’s clinician-led management team remains significant investors and will continue to lead the company while Novo Holdings exited its investment; the capital will support accelerated growth and expanded access to infusion care nationwide.
-
Veranex Acquires Fusion Biotec
December 13, 2022
Medical Devices
Veranex has acquired Fusion Biotec, a Southern California design and engineering firm specializing in complex electro-mechanical diagnostic instrumentation and medical devices. The acquisition brings Fusion's 15,000-square-foot facility and 45+ engineering staff into Veranex's Product Design & Engineering capabilities, expanding Veranex's diagnostic/IVD development, software/firmware reuse and Southern California footprint; financial terms were not disclosed.
-
Novo Holdings Acquires KabaFusion from Pritzker Private Capital
November 2, 2022
Healthcare Services
Novo Holdings has acquired KabaFusion, a national provider of home infusion therapies, from Pritzker Private Capital. KabaFusion's clinician-led management team will remain significant investors and will continue to run the business as Novo supports continued growth and expansion of its nationwide home infusion network.
-
KabaFusion Acquires Lincare's Infusion Pharmacies
March 4, 2020
Healthcare Services
KabaFusion acquired the home infusion assets of Lincare (a subsidiary of Linde plc), expanding its network of specialty home infusion pharmacies and strengthening its clinician-led capabilities in IVIG and other infusion therapies. The deal—KabaFusion's first acquisition since partnering with Pritzker Private Capital—adds 28 infusion pharmacies and expands the combined company's licensed reach to serve patients in 44 states; terms were not disclosed.
-
Veeva Systems Acquires Crossix Solutions for $430 Million
November 1, 2019
Data & Analytics
Veeva Systems acquired Crossix Solutions for $430 million in a transaction announced September 26, 2019 and closed November 1, 2019. Crossix — a privacy-safe patient data and analytics provider headquartered in New York City — will operate as an independent business unit within Veeva, with Crossix CEO Asaf Evenhaim continuing to lead; certain Crossix employees received long-term equity retention grants valued at about $120 million.
-
Nicox S.A. Acquires Aciex Therapeutics, Inc.
July 2, 2014
Pharmaceuticals
Nicox S.A. agreed to acquire Aciex Therapeutics, Inc., a U.S.-based ophthalmic development company, in a share-exchange deal that will transfer 100% of Aciex to Nicox. The transaction (approved by Nicox shareholders on October 22, 2014) issues 20,627,024 new Nicox shares for Aciex equity and includes contingent value rights giving up to $55 million in potential additional consideration tied to FDA approvals, and is intended to broaden Nicox's ophthalmic development pipeline.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.